feed,title,long_url,short_url
SeekingAlpha,Amarin 8% higher after Sarissa wins proxy battle with management,https://seekingalpha.com/news/3941930,
SeekingAlpha,Trip.com: Positives Priced In,https://seekingalpha.com/article/4582847,
SeekingAlpha,"CVR Partners: 2023 Results Will Likely Be Below 2022, But Still Solid",https://seekingalpha.com/article/4582846,
SeekingAlpha,Horizon Therapeutics: Attractive 5.4% Upside To Amgen Offer,https://seekingalpha.com/article/4582845,
